{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:37:58Z","timestamp":1780580278624,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T00:00:00Z","timestamp":1548460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10096-019-03490-6","type":"journal-article","created":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T03:21:31Z","timestamp":1548472891000},"page":"703-709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome"],"prefix":"10.1007","volume":"38","author":[{"given":"Camille","family":"Klotz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Courjon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Michelangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Demonchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Ruimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,26]]},"reference":[{"key":"3490_CR1","doi-asserted-by":"crossref","unstructured":"Erysip\u00e8le et fasciite n\u00e9crosante. Prise en charge. Conf\u00e9rence de consensus (2000) Med Mal Inf 30(Suppl 4):252\u201372","DOI":"10.1016\/S0399-077X(01)80012-3"},{"key":"3490_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0151-9638(05)79249-8","volume":"132","author":"P Bernard","year":"2005","unstructured":"Bernard P, Christmann D, Morel M (2005) Management of erysipelas in French hospitals: a post-consensus conference study. Ann Dermatol Venereol 132:213\u2013217","journal-title":"Ann Dermatol Venereol"},{"key":"3490_CR3","unstructured":"Food and Drug Administration (2013) Guidance for industry: acute bacterial skin and skin structure infections developing drugs for treatment. \n                    www.fda.gov\/downloads\/Drugs\/Guidances\/ucm071185.pdf\n                    \n                  . Accessed 24 August 2016"},{"key":"3490_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1749-7922-9-57","volume":"9","author":"M Sartelli","year":"2014","unstructured":"Sartelli M, Malangoni MA, May AK, Viale P, Kao LS, Catena F et al (2014) WSES guidelines for management of SSTI. World J Emerg Surg 9:57","journal-title":"World J Emerg Surg"},{"issue":"1","key":"3490_CR5","doi-asserted-by":"publisher","first-page":"ofx188","DOI":"10.1093\/ofid\/ofx188","volume":"5","author":"RS Kamath","year":"2018","unstructured":"Kamath RS, Sudhakar D, Gardner JG, Hemmige V, Safar H, Musher DM (2018) Guidelines vs actual management of skin and soft tissue infections in the emergency department. Open Forum Infect Dis 5(1):ofx188","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"3490_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1086\/678056","volume":"35","author":"TC Jenkins","year":"2014","unstructured":"Jenkins TC, Knepper BC, Moore SJ, O\u2019Leary ST, Caldwell B, Saveli CC et al (2014) Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection. Infect Control Hosp Epidemiol 35(10):1241\u20131250","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"3490_CR7","first-page":"383","volume":"51","author":"L Lazzarini","year":"2005","unstructured":"Lazzarini L, Conti E, Tositti G, Lalla F (2005) Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Inf Secur 51(5):383\u2013389","journal-title":"J Inf Secur"},{"issue":"2","key":"3490_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.diagmicrobio.2014.02.011","volume":"79","author":"BB Lipsky","year":"2014","unstructured":"Lipsky BB, Napolitano LM, Moran GJ, Vo L, Nicholson S, Kim M (2014) Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors. Diagn Microbiol Infect Dis 79(2):273\u2013279","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"3490_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/s12879-016-2067-0","volume":"16","author":"TL Walsh","year":"2016","unstructured":"Walsh TL, Chan L, Konopka CI, Burkitt MJ, Moffa MA, Bremmer DN et al (2016) Appropriateness of antibiotic management of uncomplicated SSTIs in hospitalized adult patients. BMC Infect Dis 16(1):721","journal-title":"BMC Infect Dis"},{"issue":"5","key":"3490_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.medmal.2017.03.005","volume":"47","author":"PM Roger","year":"2017","unstructured":"Roger PM, Demonchy E, Risso K, Courjon J, Leroux S, Leroux E et al (2017) Medical table: a major tool for antimicrobial stewardship policy. Med Mal Infect 47(5):311\u2013318","journal-title":"Med Mal Infect"},{"issue":"1","key":"3490_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1155\/1998\/538090","volume":"9","author":"M Smieja","year":"1998","unstructured":"Smieja M (1998) MD FRCPC DTM&H, Current indications for the use of clindamycin: a critical review. Can J Infect Dis 9(1):22\u201328","journal-title":"Can J Infect Dis"},{"issue":"2","key":"3490_CR12","first-page":"148","volume":"64","author":"CG Gunderson","year":"2012","unstructured":"Gunderson CG, Martinello RA (2012) A systematic review of bacteraemia in cellulitis and erysipelas. J Inf Secur 64(2):148\u2013155","journal-title":"J Inf Secur"},{"issue":"5","key":"3490_CR13","first-page":"143","volume":"4","author":"A Pulido-Cejudo","year":"2017","unstructured":"Pulido-Cejudo A, Guzm\u00e1n-Gutierrez M, Jalife-Monta\u00f1o A, Ortiz-Covarrubias A, Mart\u00ednez-Ordaz JL, Noyola-Villalobos HF et al (2017) Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure. Ther Adv Infect Dis 4(5):143\u2013161","journal-title":"Ther Adv Infect Dis"},{"issue":"2","key":"3490_CR14","first-page":"128","volume":"65","author":"J Halilovic","year":"2012","unstructured":"Halilovic J, Heintz BH, Brown J (2012) Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess. J Inf Secur 65(2):128\u2013134","journal-title":"J Inf Secur"},{"issue":"6","key":"3490_CR15","first-page":"431","volume":"60","author":"M Figtree","year":"2010","unstructured":"Figtree M, Konecny P, Jennings Z, Goh C, Krilis SA, Miyakis S (2010) Risk stratification and outcome of cellulitis admitted to hospital. J Inf Secur 60(6):431\u2013439","journal-title":"J Inf Secur"},{"issue":"Suppl. 7","key":"3490_CR16","doi-asserted-by":"publisher","first-page":"S469","DOI":"10.1093\/cid\/cir162","volume":"52","author":"GR Corey","year":"2011","unstructured":"Corey GR, Stryjewski ME (2011) New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good. Clin Infect Dis 52(Suppl. 7):S469\u2013S476","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3490_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1067\/mcp.2001.120762","volume":"70","author":"C Joukhadar","year":"2001","unstructured":"Joukhadar C, Klein N, Frossard M, Minar E, Stass H, Lackner E et al (2001) Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease. Clin Pharmacol Ther 70(6):532\u2013539","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"3490_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.medmal.2014.07.013","volume":"44","author":"PM Roger","year":"2014","unstructured":"Roger PM, Cua E, Courjon J, Landraud L, Carles M, Bernard E (2014) The impact of bacteraemia on the outcome of bone infections. Med Mal Infect 44(8):380\u2013386","journal-title":"Med Mal Infect"},{"issue":"1","key":"3490_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-0034-1398742","volume":"36","author":"G Vazquez-Grande","year":"2015","unstructured":"Vazquez-Grande G, Kumar A (2015) Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy. Semin Respir Crit Care Med 36(1):154\u2013166","journal-title":"Semin Respir Crit Care Med"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03490-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03490-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03490-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T19:10:38Z","timestamp":1579979438000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03490-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,26]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["3490"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03490-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,26]]},"assertion":[{"value":"9 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Observational studies do not require ethical approval in France. Antimicrobial stewardship is promoted by the French National Health Agency. Internal dashboard is declared to French Data Protection Authority, number 1430722.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patients or their relatives provided their written consent for digitization of their personal data for hospitalization purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}